Lord, Abbett & Co. LLC Electro Core, Inc. Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.65 - $6.72 $346,920 - $1.41 Million	-210,255 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.84 - $9.07 $24,495 - $45,903	-5,061 Reduced 2.35%	210,255 $1.47 Million
Q4 2018 Feb 14, 2019	SELL	$4.21 - $14.28 $732,851 - $2.49 Million	-174,074 Reduced 44.7%	215,316 $1.35 Million
Q3 2018 Nov 14, 2018	BUY	$13.02 - $17.54 $449,567 - $605,638	34,529 Added 9.73%	389,390 $5.45 Million
Q2 2018 Aug 14, 2018	BUY	$16.51 - $19.85 $5.86 Million - $7.04 Million	354,861 New	354,861 $5.86 Million

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $873M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.